Dave Inman

Publication Activity (10 Years)

Years Active: 2020-2020
Publications (10 Years): 1

Top Topics

Placebo Controlled

Monoclonal Antibody

Cardiovascular Disease

Top Venues

GlaxoSmithKline Research and Development

This page only lists publications with an associated author ORCID identifier.

Affiliation History

GlaxoSmithKline Research and Development Apr 01 2016

United Kingdom

Statistical Leader :: Immuno-Inflamation

Publications

Bart Keymeulen, André van Maurik, Dave Inman, João Oliveira, Rene McLaughlin, Rachel M Gittelman, Bart O Roep, Pieter Gillard, Robert Hilbrands, Frans K Gorus, Chantal Mathieu, Ursule Van de Velde, Nicolas Wisniacki, Antonella Napolitano
A randomised, single-blind, placebo-controlled, dose-finding safety and tolerability study of the anti-CD3 monoclonal antibody otelixizumab in new-onset type 1 diabetes. Diabetologia 64 (2) (2020)